Plus, news about Immunic, Neurocrine Biosciences, Alcon, AusperBio and Evommune:
Taysha Gene Therapies reveals plans for pivotal trial, $200M offering: The biotech on Wednesday disclosed design details for its pivotal Part ...
↧